http://purl.org/np/RAgGfWvIP7ymf3ZmSss5MexcCaF4Vqe6yvzT4lVHxHsjE
.trig | .trig.txt | .jelly | .jelly.txt
@prefix this: <http://purl.org/np/RAgGfWvIP7ymf3ZmSss5MexcCaF4Vqe6yvzT4lVHxHsjE> . @prefix sub: <http://purl.org/np/RAgGfWvIP7ymf3ZmSss5MexcCaF4Vqe6yvzT4lVHxHsjE#> . @prefix schema: <https://schema.org/> . @prefix np: <http://www.nanopub.org/nschema#> . @prefix dct: <http://purl.org/dc/terms/> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix nt: <https://w3id.org/np/o/ntemplate/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix orcid: <https://orcid.org/> . @prefix bl: <https://w3id.org/biolink/vocab/> . @prefix prov: <http://www.w3.org/ns/prov#> . @prefix npx: <http://purl.org/nanopub/x/> . sub:Head { this: a np:Nanopublication; np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo . } sub:assertion { <http://purl.obolibrary.org/obo/DOID_3310> bl:category bl:Disease . sub:association a rdf:Statement; rdf:object <http://purl.obolibrary.org/obo/DOID_3310>; rdf:predicate bl:treats; rdf:subject <https://identifiers.org/drugbank:DB00337>; rdfs:label "pimecrolimus cream 1 is indicated as second line therapy for the short term and non continuous chronic treatment of mild to moderate atopic dermatitis in non immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable pimecrolimus cream 1 is not indicated for use in children less than 2 years of age warnings and precautions 5 1 use in specific populations 8 4 pimecrolimus cream 1 is a calcineurin inhibitor immunosuppressant indicated as second line therapy for the short term and non continuous chronic treatment of mild to moderate atopic dermatitis in non immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable 1"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by <https://w3id.org/um/NeuroDKG>; bl:relation schema:TreatmentIndication . <https://identifiers.org/drugbank:DB00337> bl:category bl:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "MEf5YGvLKJmJtbW1tRC/Wjk2424dj2de1+sLXDHG8I2BnwFOytNEaFYuIPD/ag5SFZaoW5s/4nVuh0cEVLDmTf7OJdIosAm6i5KO4oo8/oZsmTKpJncczV0eygSBtfxtXvpnQ/6zUt+mu0qDyMCdh3BuqJn774r70W83WNTuPv0="; npx:hasSignatureTarget this: . this: dct:created "2021-06-19T08:33:46.235+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>; nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>; nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> . }